- Latest news▼
-
22:46, September 3 At-Home Urine Test Could Detect Most Bladder Cancer Cases, Study Finds
-
20:38, September 3 Alcohol-Related Cancer Deaths Double in the U.S. as the Number of Such Deaths Rises Over 33 Years
-
18:29, September 3 An Unexpected Paradox: Both Very Low and Very High Testosterone Levels May Be Equally Dangerous for the Heart
-
16:11, September 3 The Independent: Aging Is the Main Risk Factor for Cancer
-
14:13, September 3 CC: Age-Related Changes in Memory May Begin as Early as 50
-
08:34, September 3 Scientists Find Who May Benefit More from Coffee in Terms of Parkinson’s Disease Risk
-
23:37, September 2 LDE: Popular Diabetes Drugs Linked to Risk of a Dangerous Complication in Certain Patients
-
19:45, September 2 European Journal of Nutrition: Some Additives in Ultra-Processed Foods May Be Linked to Depression Risk
-
17:29, September 2 Neuron: Human Brain Immune Cells Mature Hundreds of Times More Slowly Than Those in Mice
-
15:21, September 2 Frontiers in Nutrition: Sucralose and Stevia Altered the Gut Microbiome for Two Generations in Mice
-
13:13, September 2 Frontiers: Frequent Consumption of Sugary Drinks Linked to a 23% Higher Risk of ADHD in Children
-
11:12, September 2 Food & Function: Nuts May Accelerate Blood Vessel Recovery After Stroke
-
08:39, September 2 Scientists Discover Hidden Sign of Crohn’s Disease and Ulcerative Colitis Before a Flare-Up
-
22:41, September 1 Not Just APOE4: Scientists Identify 44 Genes That May Alter Alzheimer’s Risk
-
20:39, September 1 The Word “Diet” May Put Men Off: Study Suggests Easier Ways for Them to Lose Weight
All materials
LinkedIn founder, renowned cancer researcher launch AI-powered drug discovery startup
LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an AI-powered drug discovery startup, Manas AI, reports TechCrunch.
Manas AI claims it will design molecules with AI, then test them in a wet lab, Hoffman reportedly said during the presentation of his new book “Superagency.”
The outfit also says it will use Microsoft’s cloud computing platform, Azure, and Microsoft’s “deep domain knowledge in AI” to develop novel medicines.
Hoffman has close ties to Microsoft, which famously acquired his earlier company, LinkedIn, in a blockbuster deal in 2016.
Manas AI, which will initially focus on breast cancer, prostate cancer, and lymphoma, has raised $24.6 million in seed funding from Hoffman, General Catalyst, and Greylock.
But the company’s aforesaid capital haul pales compared with some other startups trying to use AI models to develop novel drugs. Last year, Xaira, which claimed that it was ready to start developing drugs, launched with a massive $1 billion in initial funding. Treeline Biosciences is another company that uses AI for drug discovery and raised $422 million last year, Endpts reported.
Follow NEWS.am Medicine on Facebook and Twitter
- Related News
- Patient with Metastatic Pancreatic Cancer Remains Disease-Free for More Than Three Years After Experimental Treatment The study involved 11 patients with newly diagnosed metastatic pancreatic cancer who had not previously received treatment...
- When Parents Live to 100: How Their Children Differ From Others A total of 2,329 offspring of centenarians and 2,703 people in a control group were included in the analysis. The first group had at least one parent who had reached the age of 100.․․
- Donor Stem Cell Transplants Offer Hope of Long-Term Survival in Rare Aggressive Lymphoma Hepatosplenic T-cell lymphoma is an uncommon and highly aggressive cancer that affects the blood and lymphatic system...
- Pioneering fetal surgery corrects severe birth defect before baby is born The procedure was carried out on London resident Maisie Savage when she was 26 weeks pregnant...
- The Secret of Italian Longevity: Scientists Reveal Where the Most Centenarians Live in Italy At the same time, several southern areas also demonstrate remarkable longevity patterns...
- Most read
month
week
day
- Immunity: COVID-19 May Trigger a Mechanism Similar to the Development of Autoimmune Diseases 692
- AI Assesses the Risk of Hypertension and Other Systemic Diseases From Eye Fundus Images 560
- An Unexpected Paradox: Both Very Low and Very High Testosterone Levels May Be Equally Dangerous for the Heart 510
- European Journal of Nutrition: Some Additives in Ultra-Processed Foods May Be Linked to Depression Risk 493
- LDE: Popular Diabetes Drugs Linked to Risk of a Dangerous Complication in Certain Patients 490
- Frontiers in Nutrition: Sucralose and Stevia Altered the Gut Microbiome for Two Generations in Mice 487
- Extreme Temperatures May Raise the Risk of Hospitalization for Heart Failure 486
- Adolescent Alcohol Use Disrupts Brain Cell Connections and Alters Adult Behavior 476
- Alcohol-Related Cancer Deaths Double in the U.S. as the Number of Such Deaths Rises Over 33 Years 474
- SciSign: Cancer-Associated Protein BRAF Identified as a Potential Driver of Chronic Pain 464
- Neuron: Human Brain Immune Cells Mature Hundreds of Times More Slowly Than Those in Mice 451
- Missing Summer Already? Simple Ways to Beat the Back-to-Work Blues 450
- Frontiers: Frequent Consumption of Sugary Drinks Linked to a 23% Higher Risk of ADHD in Children 446
- Not Just APOE4: Scientists Identify 44 Genes That May Alter Alzheimer’s Risk 443
- CC: Age-Related Changes in Memory May Begin as Early as 50 439
- Find us on Facebook
- Poll